stars 1 stars 2 stars 3

Akros Bioscience has been helping its clients in the design of preclinical and clinical development plans for over 10 years for the companies operating in the domains of pharmaceutical-biotechnology, medical devices, food additives/nutraceuticals and cosmetics. We assist our customers in the development of their products, from the regulatory framework, to the toxicological evaluation, to the design and supervision of preclinical tests and clinical studies, to the preparation of the technical-scientific documentation to support the products (Biological Evaluation Report, Clinical Evaluation Report , Preclinical and Clinical Development Plan etc.). We have experience in the main therapeutic areas such as neurology, oncology, cardiovascular diseases, ophthalmology and stomatology. I ask your availability for a short videoconference to evaluate how we can assist you in your projects. With the full effectiveness of the 2017/745 regulation, qualified support is increasingly important and we think that a company like ours could prove to be very useful in the development of devices and drugs.

Akros BioScience srl Questions

The Akros BioScience srl annual revenue was $1 million in 2026.

7 people are employed at Akros BioScience srl.

Akros BioScience srl is based in Pomezia, Latium.

The NAICS codes for Akros BioScience srl are [54, 541713, 5417, 541, 54171].

The SIC codes for Akros BioScience srl are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users